Completion of the clinical phase of randomized, double blind, placebo controlled pilot study conducted in India to evaluate safety and efficacy of orally administered IMA001 in sickle cell disease patients.
Imalia Announces Completion of Clinical Phase of French Pilot Study Evaluating IMA001 in Sickle Cell Disease
Completion of the clinical phase of the monocentric, prospective, open label pilot study conducted